Medical Stocks To Research - March 27th

Key Points

• MarketBeat flagged UnitedHealth Group (UNH), Artelo Biosciences (ARTL), and Eli Lilly (LLY) as the three Medical stocks to watch today based on the highest dollar trading volume in recent days.
• UnitedHealth Group (UNH) is a diversified U.S. healthcare company operating four segments—including UnitedHealthcare and Optum—that provide employer, Medicare, Medicaid, pharmacy and health‑services offerings.
• Artelo Biosciences (ARTL) is a clinical‑stage biotech developing cannabinoid and FABP5‑targeting therapies for conditions such as cancer‑related anorexia, neuropathies and anxiety, while Eli Lilly (LLY) is a major pharmaceutical firm known for diabetes and obesity drugs like Mounjaro, Trulicity and Zepbound.

UnitedHealth Group, Artelo Biosciences, and Eli Lilly and Company are the three Medical stocks to watch today, according to MarketBeat's stock screener tool. Medical stocks are shares of publicly traded companies involved in healthcare — including pharmaceuticals, biotechnology, medical devices, diagnostics, hospitals, and health-services firms. Investors treat them as a distinct sector because performance is driven by clinical trial results, regulatory approvals, patent and reimbursement dynamics, demographic trends, and can be both growth-oriented and event‑driven/volatile. These companies had the highest dollar trading volume of any Medical stocks within the last several days.

UnitedHealth Group (UNH)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Read Our Latest Research Report on UNH

Artelo Biosciences (ARTL)

Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, develops and commercializes therapeutics that target lipid-signaling pathways in the United States. It's product candidate pipeline includes ART27.13, a synthetic dual cannabinoid G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of anorexia associated with cancer; ART12.11, a synthetic cannabidiol cocrystal for the treatment anxiety, post-traumatic stress disorder, epilepsy, inflammatory bowel disease, and other potential indications; and ART26.12, a fatty acid binding protein 5 inhibitor for treating chemotherapy induced peripheral neuropathy, diabetic neuropathy, prostate cancer and breast cancer, pain, dermatologic conditions, and anxiety disorders.

Read Our Latest Research Report on ARTL

Eli Lilly and Company (LLY)

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.

Read Our Latest Research Report on LLY

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.